Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II

Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II

Background. Enzyme replacement therapy (ERT) with iduronate-2-sulfatase recombinant forms (idursulfase and idursulfase beta) is effective for the management of mucopolysaccharidosis type II (MPS II). Patients with Hunter syndrome require lifelong ERT that can negate endogenous enzyme deficiency. How...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia G. Levina, Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Elena A. Vishneva, Mariya S. Karaseva, Natalia V. Zhurkova, Kamilla E. Efendieva, Anna A. Alekseeva, Vera G. Kalugina, Artur V. Zaz’yan
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2022-07-01
Series:Педиатрическая фармакология
Subjects:
mucopolysaccharidosis type ii
hunter syndrome
enzyme replacement therapy
idursulfase
idursulfase beta
drug allergy
urticaria
children
clinical case
Online Access:https://www.pedpharma.ru/jour/article/view/2178
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.pedpharma.ru/jour/article/view/2178

Similar Items